Extra-immunization as a clinical indicator for fragmentation of care

Public Health Reports

Volumn 126, Issue SUPPL. 2, 2011, Pages 48-59

  Darden, Paul M ^a   Gustafson, Kristina K ^b   Nietert, Paul J ^b   Jacobson, Robert M ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; VACCINE;

ADULT; ARTICLE; ETHNICITY; FEMALE; HEALTH CARE; HEALTH CARE FACILITY; HISPANIC; HUMAN; IMMUNIZATION; MALE; PRIORITY JOURNAL; RACE; VACCINATION; HEALTH CARE QUALITY; INFANT; PATIENT CARE; PRESCHOOL CHILD; SOCIOECONOMICS; STATISTICS;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PATIENT-CENTERED CARE; QUALITY INDICATORS, HEALTH CARE; SOCIOECONOMIC FACTORS; VACCINES;

EID: 80052069769     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549111260s207     Document Type: Article

References (36)

1. American Academy of Pediatrics Medical Home Initiatives for Children with Special Needs Project Advisory Committee. Policy statement: organizational principles to guide and define the child health care system and/or improve the health of all children. Pediatrics 2004;113(5 Suppl):1545-7.
2. American Academy of Pediatrics Medical Home Initiatives for Children with Special Needs Project Advisory Committee. The medical home. Pediatrics 2002;110(1 Pt 1):184-6.
3. Cabana MD, Jee SH. Does continuity of care improve patient outcomes? J Fam Pract 2004;53:974-80.
4. Heagarty MC, Robertson LS, Kosa J, Alpert JJ. Some comparative costs in comprehensive versus fragmented pediatric care. Pediatrics 1970;46:596-603.
5. Allred NJ, Wooten KG, Kong Y. The association of health insurance and continuous primary care in the medical home on vaccination coverage for 19-to 35-month-old children. Pediatrics 2007;119 Suppl 1:S4-11.
6. Christakis DA. Does continuity of care matter? Yes: consistent contact with a physician improves outcomes. West J Med 2001;175:4.
7. Christakis DA, Mell L, Wright JA, Davis R, Connell FA. The association between greater continuity of care and timely measles-mumpsrubella vaccination. Am J Public Health 2000;90:962-5.
8. Smith PJ, Santoli JM, Chu SY, Ochoa DQ, Rodewald LE. The association between having a medical home and vaccination coverage among children eligible for the Vaccines for Children program. Pediatrics 2005;116:130-9.
9. Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K. Improved outcomes associated with medical home implementation in pediatric primary care. Pediatrics 2009;124:358-64.
10. Starfield B. The Medical Home Index applies primarily to children with special health care needs. Ambul Pediatr 2004;4:192.
11. American Academy of Pediatrics Ad Hoc Task Force on Definition of the Medical Home. The medical home. Pediatrics 1992;90:774.
12. Yawn BP, Yawn RA, Geier GR, Xia Z, Jacobsen SJ. The impact of requiring patient authorization for use of data in medical records research. J Fam Pract 1998;47:361-5.
13. Feikema SM, Klevens RM, Washington ML, Barker L. Extraimmunization among US children. JAMA 2000;283:1311-7.
14. Davis RL. Vaccine extraimmunization-too much of a good thing? JAMA 2000;283:1339-40.
15. Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, et al. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics 2003;111:296-301.
16. Strine TW, Barker LE, Jain RB, Washington ML, Chu SY, Mokdad AH. Extraimmunization in children through 2000. JAMA 2002;287:588-9.
17. Rabo E. [Risk of overvaccination against tetanus-who is deciding: the National Board of Health and Welfare or the manufacturer?] Lakartidningen 1989;86:615-6.
18. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523-30.
19. Zell ER, Ezzati-Rice TM, Battaglia MP, Wright RA. National Immunization Survey: the methodology of a vaccination surveillance system. Public Health Rep 2000;115:65-77.
20. Recommended childhood immunization schedule-United States, 1999. MMWR Morb Mortal Wkly Rep 1999;48(1):12-6.
21. Recommended childhood immunization schedule-United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49(2):35-8, 47.
22. Recommended childhood immunization schedule-United States, 2001. MMWR Morb Mortal Wkly Rep 2001;50(1):7-10, 19.
23. Recommended childhood immunization schedule-United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51(2):31-3.
24. Recommended childhood and adolescent immunization schedule. United States, 2003 [published erratum appears in MMWR Morb Mortal Wkly Rep 2003;52(9):191]. MMWR Morb Mortal Wkly Rep 2003;52(4):Q1-4.
25. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998;47(RR-8):1-57.
26. SAS Institute, Inc. SAS®: Version 9.1 for Windows. Cary (NC): SAS Institute, Inc.; 2008.
27. StataCorp. Stata®: Version 8.0. College Station (TX): StataCorp; 2004.
28. McElligott JT, Darden PM. Are patient-held vaccination records associated with improved vaccination coverage rates? Pediatrics 2010;125:e467-72.
29. Jones AE, Melville-Smith M, Watkins J, Seagroatt V, Rice L, Sheffield F. Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines. Community Med 1985;7:99-106.
30. Borgono JM, McLean AA, Vella PP, Woodhour AF, Canepa I, Davidson WL, et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med 1978;157:148-54.
31. Borrow R, Joseph H, Andrews N, Longworth E, Martin S, Peake N, et al. Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults. Vaccine 2000;19:1129-32.
32. MacLennan J, Obaro S, Deeks J, Williams D, Pais L, Carlone G, et al. Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. Vaccine 1999;17:3086-93.
33. Advisory Committee on Immunization Practices update: report of PedvaxHIB lots with questionable immunogenicity. MMWR Morb Mortal Wkly Rep 1992;41(46):878-9.
34. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum appears in MMWR Morb Mortal Wkly Rep 2006;55(48):1303]. MMWR Recomm Rep 2006;55(RR-15):1-48.
35. Luman ET, Shaw KM, Stokley SK. Compliance with vaccination recommendations for U.S. children [published erratum appears in Am J Prev Med 2008;35:319]. Am J Prev Med 2008;34:463-70.
36. Smith PJ, Stevenson J. Racial/ethnic disparities in vaccination coverage by 19 months of age: an evaluation of the impact of missing data resulting from record scattering. Stat Med 2008;27:4107-18.